Insider trade

CEO received an award of 332 AGX derivative securities

Traded Apr 8, 2026 · Filed Apr 10, 2026

Argan, Inc.AGX

332
Derivative units

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Apr 8, 2026
Reporting period: Not applicable
Filed with the SEC: Apr 10, 2026

CEOGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001791800-26-000002
Filed / recorded

Apr 10, 2026, 8:30 PM UTC

Added to OQRO

Oct 6, 2026, 9:54 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

ARGAN INC

Issuer CIK

100591

Ticker

AGX

Reporting person

Charles Edwin Iv Collins

Relationship

Officer

Officer title

CHIEF EXECUTIVE OFFICER, GEMMA

Security

Option to Purchase Common Stock

Table

Derivative (Table II)

Transaction date

Apr 8, 2026

Transaction code

A

Shares / units

332

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

15,067

Ownership form

Direct

Amendment

No

Footnotes from the filing

On April 8, 2026, the Reporting Person received 10-year options to purchase 332 shares of the Issuer's common stock with an exercise price of $588.28 per share. The options will vest ratably over three years on each anniversary of the grant date starting on 4/8/2027.